BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Nephrol. Jun 25, 2026; 15(2): 118253
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.118253
Table 1 Characteristics of patients receiving early and late steroids, n (%)
Variables
Early (n = 84)
Late (n = 44)
P value (df for χ2)
Age in years [median (IQR)]30 (25-38)30 (26-37)0.94
Gender (male)78 (92.9)40 (90.0)0.74 (1)
Dose of pulse steroid in mg [median (IQR)]1500 (1500-1500)1500 (1500-1500)0.48
HLA mismatch [median (IQR)]3 (3-5)3 (3-4)0.94
ABO compatible77 (91.7)40 (90.9)1.0 (1)
Diabetes status0.52 (2)
Pre-existing DM1 (1.2)2 (4.5)
PTDM9 (10.7)4 (9.1)
No diabetes74 (88.1)38 (86.4)
CMV prophylaxis40 (47.6)19 (43.2)0.63 (1)
Graft loss2 (2.4)1 (2.3)1.0 (1)
Survival status0.02 (1)
Alive80 (95.2)36 (81.8)
Died4 (4.8)8 (18.2)


Write to the Help Desk